Category Archives: Pr Newswire

Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026

ROCKVILLE, Md. and SUZHOU, China, March 17, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that four abstracts highlighting the latest preclinical results from its […]

NatureGlyco Blood Support Claims Evaluated: The Proven Glyco Care Formula for Healthy Blood Sugar Support

A 2026 company-issued informational report covering NatureGlyco’s product descriptions, ingredient references, pricing, subscription terms, and consumer verification points for adults researching blood sugar support options Wilmington, Delaware, March 17, 2026 (GLOBE NEWSWIRE) — This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any […]

Mesoblast to Host R&D Day on April 8, 2026

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host its inaugural R&D Day on Wednesday, April 8, 2026 in New York City. The event will be webcast live from 8:00am to 11:00am EST and will include presentations from Mesoblast’s senior leadership […]

DentaBiome Claims Evaluated: 2026 Oral Postbiotic Consumer Warning Report Issued

A 2026 consumer warning report examining DentaBiome’s oral postbiotic formula, how FabM acid-lock and 30-second kitchen method claims relate to published research, the ingredient research context commonly cited in this category, the published pricing structure, and which details consumers may wish to verify through publicly available materials Tallmadge, OH, March 17, 2026 (GLOBE NEWSWIRE) — […]

MEDVi GLP-1 Weight Loss Claims Evaluated: 2026 Report Examining “Most Trusted Online Medical Care” Positioning, Telehealth Structure, and Regulatory Context

A 2026 informational evaluation of MEDVi’s GLP-1 weight loss program structure, compounded semaglutide and branded Ozempic access pathways, published pricing disclosures, three-entity telehealth model, refund terms, and the regulatory and disclosure context relevant to online GLP-1 treatment programs Newark, DE, March 17, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It […]

Vieworks to Debut VISQUE DPS LH210 at USCAP 2026, a Single Scanner for Both Cytology and Histology

High-throughput, mid capacity LH210 expands the VISQUE DPS lineup with fast scanning, optimized data size, and scalable digital pathology workflow ANYANG, South Korea, March 18, 2026 /PRNewswire/ — Vieworks, a global provider of advanced imaging solutions, will participate in USCAP 2026 (United States & Canadian Academy of Pathology Annual Meeting), held from March 23 to 25 […]

Breakthrough at 2026 AACR! Senhwa Biosciences’ CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy

TAIPEI and SAN DIEGO, March 18, 2026 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its first-in-class investigational drug Pidnarulex (CX-5461) has demonstrated a significant research breakthrough in the field of photodynamic therapy (PDT). The research […]

New Deloitte Paper: Physical AI set to transform industrial operations, powering the next wave of smart manufacturing

HONG KONG, March 18, 2026 /PRNewswire/ — Deloitte today released its new paper, “Physical AI: The moment of acceleration“, outlining how Physical AI (PAI), the merger of physical systems with AI, is shifting from experimentation to large-scale deployment across a wide range of business sectors and applications. The report underscores why industrial robotics has become […]

ZTO Reports Fourth Quarter 2025 and Full Year 2025 Unaudited Financial Results

Full Year Adjusted Net Income Reached RMB9.5 BillionUS$0.39 per Share Semi-Annual Dividend AnnouncedUS$1.5 Billion New Share Repurchase Program Authorized SHANGHAI, March 18, 2026 /PRNewswire/ — ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading and fast-growing express delivery company in China (“ZTO” or the “Company”), today announced its unaudited financial results for the […]

YY Group Announces Strategic Investment in Arros AI, an NVIDIA Inception Program Member

AI and Robotics Collaborations, Expanding Manpower Client Portfolio, and Growing IFM Pipeline Reinforce FY2026 Revenue Guidance of US$103 Million to US$110 Million Strengthening Next-Generation Workforce Technology and AI Hiring Infrastructure SINGAPORE, March 18, 2026 /PRNewswire/ —  YY Group Holding Limited (NASDAQ: YYGH) (“YY Group” or the “Company”), a global leader in on-demand workforce solutions and […]